Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Didier Bouscary

Showing results (1-10 of 156) with videos related to

Pageof 16
Sort By:
Annals of Translational Medicine|November 22, 2016
Rational for targeting the hedgehog signalling pathway in acute myeloid leukemia with FLT3 mutationDidier Bouscary
Oncoscience|January 17, 2015
Targeting glutamine uptake in AMLNathalie Jacque, Didier Bouscary
Frontiers in Oncology|October 12, 2020
From Iron Chelation to Overload as a Therapeutic Strategy to Induce Ferroptosis in Leukemic CellsEric Grignano, Rudy Birsen, Nicolas Chapuis, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|June 4, 2026
Radiotherapy as a curative strategy for primary pleural indolent lymphomas: Analytical guidelines based on literature and an illustrative population-based case seriesPierre Loap, Lise Willems, Didier Bouscary, et al.
Medecine Sciences : M/S|October 21, 2015
[Co-activation of AMPK and mTORC1: a therapeutic application of synthetic lethality in acute myeloid leukemia]Jérôme Tamburini, Laury Poulain, Didier Bouscary, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 8, 2022
Pediatric Plasma Cell Neoplasms: A Population-Based StudyPierre Loap, Marguerite Vignon, Didier Bouscary, et al.
Medecine Sciences : M/S|September 7, 2021
[Ferroptosis and cancer: Physiopathological and therapeutic implications]Rudy Birsen, Eric Grignano, Nicolas Chapuis, et al.
BMJ Case Reports|June 22, 2022
Visceral leishmaniasis: an unusual cause of isolated lymphadenopathyPatricia Palmic, Philippe Blanche, Didier Bouscary, et al.
Leukemia & Lymphoma|October 9, 2010
Rituximab-induced life-threatening coagulopathy occurring in a patient with Waldenström macroglobulinemia treated with fludarabine, cyclophosphamide, and rituximab combinationSylvain Pilorge, Sophie Park, François Dreyfus, et al.
Cancer Research|August 12, 2010
Insulin receptor A and IGF-1R in AML - LetterNicolas Chapuis, Catherine Lacombe, Jerome Tamburini, et al.
Pageof 16

Showing results (1-10 of 156) with videos related to

Sort By:
Pageof 16
Annals of Translational Medicine|November 22, 2016
Rational for targeting the hedgehog signalling pathway in acute myeloid leukemia with FLT3 mutationDidier Bouscary
Oncoscience|January 17, 2015
Targeting glutamine uptake in AMLNathalie Jacque, Didier Bouscary
Frontiers in Oncology|October 12, 2020
From Iron Chelation to Overload as a Therapeutic Strategy to Induce Ferroptosis in Leukemic CellsEric Grignano, Rudy Birsen, Nicolas Chapuis, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|June 4, 2026
Radiotherapy as a curative strategy for primary pleural indolent lymphomas: Analytical guidelines based on literature and an illustrative population-based case seriesPierre Loap, Lise Willems, Didier Bouscary, et al.
Medecine Sciences : M/S|October 21, 2015
[Co-activation of AMPK and mTORC1: a therapeutic application of synthetic lethality in acute myeloid leukemia]Jérôme Tamburini, Laury Poulain, Didier Bouscary, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 8, 2022
Pediatric Plasma Cell Neoplasms: A Population-Based StudyPierre Loap, Marguerite Vignon, Didier Bouscary, et al.
Medecine Sciences : M/S|September 7, 2021
[Ferroptosis and cancer: Physiopathological and therapeutic implications]Rudy Birsen, Eric Grignano, Nicolas Chapuis, et al.
BMJ Case Reports|June 22, 2022
Visceral leishmaniasis: an unusual cause of isolated lymphadenopathyPatricia Palmic, Philippe Blanche, Didier Bouscary, et al.
Leukemia & Lymphoma|October 9, 2010
Rituximab-induced life-threatening coagulopathy occurring in a patient with Waldenström macroglobulinemia treated with fludarabine, cyclophosphamide, and rituximab combinationSylvain Pilorge, Sophie Park, François Dreyfus, et al.
Cancer Research|August 12, 2010
Insulin receptor A and IGF-1R in AML - LetterNicolas Chapuis, Catherine Lacombe, Jerome Tamburini, et al.
Pageof 16